Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Mapel

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Opinion in Pulmonary Medicine|December 28, 2013
Renal and hepatobiliary dysfunction in chronic obstructive pulmonary diseaseDouglas Mapel
Helicobacter|October 17, 2012
The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United StatesDouglas Mapel, Melissa Roberts, Andrew Overhiser, et al.
Journal of Medical Economics|July 21, 2012
Changes in COPD demographics and costs over 20 yearsChristopher M Blanchette, Anand A Dalal, Douglas Mapel
Managed Care Interface|April 28, 2004
The cost of chronic obstructive pulmonary disease and its effects on managed careDouglas Mapel, Joyce C Chen, Dorothy George, et al.
Journal of Medical Economics|September 28, 2011
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD managementMelissa Roberts, Douglas Mapel, Hans Petersen, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|January 19, 2010
Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilatorsDouglas Mapel, Michael Schum, Marianne Yood, et al.
Current Medical Research and Opinion|September 7, 2010
Adherence to controller therapy for chronic obstructive pulmonary disease: a reviewMeaghan St Charles, Christopher M Blanchette, Harris Silver, et al.
Medical Sciences (Basel, Switzerland)|November 4, 2017
Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.SChristopher M Blanchette, Joshua M Noone, Glenda Stone, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2017
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapyDouglas Mapel, François Laliberté, Melissa H Roberts, et al.
Respiratory Medicine|April 9, 2024
Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the USMelissa H Roberts, Mei Sheng Duh, Kieran J Rothnie, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Opinion in Pulmonary Medicine|December 28, 2013
Renal and hepatobiliary dysfunction in chronic obstructive pulmonary diseaseDouglas Mapel
Helicobacter|October 17, 2012
The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United StatesDouglas Mapel, Melissa Roberts, Andrew Overhiser, et al.
Journal of Medical Economics|July 21, 2012
Changes in COPD demographics and costs over 20 yearsChristopher M Blanchette, Anand A Dalal, Douglas Mapel
Managed Care Interface|April 28, 2004
The cost of chronic obstructive pulmonary disease and its effects on managed careDouglas Mapel, Joyce C Chen, Dorothy George, et al.
Journal of Medical Economics|September 28, 2011
Comparative effectiveness of budesonide/formoterol and fluticasone/salmeterol for COPD managementMelissa Roberts, Douglas Mapel, Hans Petersen, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|January 19, 2010
Pneumonia among COPD patients using inhaled corticosteroids and long-acting bronchodilatorsDouglas Mapel, Michael Schum, Marianne Yood, et al.
Current Medical Research and Opinion|September 7, 2010
Adherence to controller therapy for chronic obstructive pulmonary disease: a reviewMeaghan St Charles, Christopher M Blanchette, Harris Silver, et al.
Medical Sciences (Basel, Switzerland)|November 4, 2017
Healthcare Cost and Utilization before and after Diagnosis of Pseudomonas aeruginosa among Patients with Non-Cystic Fibrosis Bronchiectasis in the U.SChristopher M Blanchette, Joshua M Noone, Glenda Stone, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 8, 2017
A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapyDouglas Mapel, François Laliberté, Melissa H Roberts, et al.
Respiratory Medicine|April 9, 2024
Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the USMelissa H Roberts, Mei Sheng Duh, Kieran J Rothnie, et al.
Pageof 2